TrialBMJ (Clinical research ed.)2022

Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.

Rebecca C Auer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.